慢性鼻炎およびアレルギー性鼻炎の患者におけるブデソニド鼻水に対する薬剤投与の決定因子
Clifford Jiajun He1, Omer Baker1, Olivia LaMonte2
1School of Medicine, University of California San Diego, La Jolla, California, USA.
International forum of allergy & rhinology
|August 29, 2025
まとめ
ブデソニドの鼻水への適合は低かったが,時間の経過とともに減少した. 副鼻腔の不快感などの要因が 服従に影響を及ぼし 手術計画や併発性疾患が 否定的な影響を及ぼしました
科学分野:
- 耳鼻喉科
- 鼻炎の研究
- 薬理学的介入
背景:
- 慢性鼻炎 (CRS) の治療には,しばしば鼻内療法が必要です.
- ブデソニド鼻水はCRSの治療の選択肢です.
- 治療の有効性には 患者さんの服従の理解が不可欠です
研究 の 目的:
- ブデソニドの鼻水への客観的な適合率を評価する.
- この治療の順守に影響を与える要因を特定する.
主な方法:
- ブデソニドの鼻水の使用を客観的に監視する.
- 患者によって報告されたアウトカムとの相関分析 (シヌス不快感,SNOT-22).
- 手術計画と併発症に基づくアデレンス評価
主要な成果:
- ブデソニドの鼻灌に対する客観的な遵守は一貫して低い.
- 研究期間中にアデバーンスが著しく減少した.
- 副鼻腔の不快感のスコアが高くなったと 粘り強さも向上しました
- 手術を予定している患者や併発性疾患の患者では,アデバーンスが低かった.
- SNOT-22のスコアは,アデレンスを予測しなかった.
結論:
- ブデソニドの鼻水への客観的な粘着は最適以下であり,時間とともに減少する.
- SNOT-22のスコアとは異なり,シヌス不快感は粘着のポジティブな予測です.
- 手術前状態と併発症は,アデバーンスが低下し,効果的な治療への潜在的な障壁を強調しています.
関連する概念動画
Drugs Used in Upper Respiratory Disorders: Overview
358
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
358
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383
Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
Drugs Used in Lower Respiratory Disorders: Overview
575
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
575
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
428
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
428


